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Editorials 835 Rebuilding the house of health care
Richard D. Lamm, LLB, CPA, Denver, Colo
839 Options for managing infected ascending aortic grafts Œ
Scott A. LeMaire, MD, and Joseph S. Coselli, MD, Houston, Tex
844 Congestive heart failure: Treat the disease, not the symptom. Return to
normalcy/Part II—The experimental approach f
Gerald D. Buckberg, MD, Los Angeles, Calif
General Thoracic
Surgery (GTS)
850 Factors predicting poor survival after resection of stage IA non–small cell
lung cancer
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L. Colson, MD, PhD,
Philip A. Linden, MD, Michael T. Jaklitsch, MD, Stuart R. Lipsitz, ScD, and
David J. Sugarbaker, MD, Boston, Mass
Analysis of 10,761 patients in the SEER database who underwent curative surgical resection of
stage IA NSCLC from 1988 to 1997 shows tumor size, gender, age, and extent of resection to
be significant predictors of 5-year survival on both univariable and multivariable analysis.
857 Radiofrequency ablation for the treatment of stage I non–small cell lung
cancer in high-risk patients
Arjun Pennathur, MD, James D. Luketich, MD, Ghulam Abbas, MD, Mang Chen, MD,
Hiran C. Fernando, MD, William E. Gooding, MS, Matthew J. Schuchert, MD, Sebastien Gilbert, MD,
Neil A. Christie, MD, and Rodney J. Landreneau, MD, Pittsburgh, Pa, and Boston, Mass
RFA was used to treat medically inoperable patients with stage I NSCLC. The median time to
local progression was 27 months. The probability of survival at 1 year was estimated to be
95%. RFA is safe in high-risk patients with stage I NSCLC with reasonable results.
865 Superior postoperative pain relief with thoracic epidural analgesia versus
intravenous patient-controlled analgesia after minimally invasive pectus
excavatum repair
Thomas Weber, MD, DEEA, Johanna Ma¨tzl, MD, Alexander Rokitansky, MD,
Walter Klimscha, MD, Konrad Neumann, PhD, and Engelbert Deusch, MD, for the Medical
Research Society, Vienna, Austria, and Berlin, Germany
In adolescents undergoing minimally invasive pectus excavatum repair, thoracic epidural
analgesia was superior to intravenous patient-controlled analgesia for postoperative analgesia,
showing lower postoperative pain scores in conjunction with higher well-being.
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871 Valuable lessons from two decades of pectus repair with the
Willital–Hegemann procedure
Amulya K. Saxena, MD, and Gunter H. Willital, MD, Graz, Austria, and Mu¨nster, Germany
Surgical correction of pectus deformities were performed on 1262 patients using the Willital–
Hegemann procedure during a 20-year period. The repairs were successful in 1244 patients
(98.6%), with a low complication rate of 5.7%. Long-term follow-up indicates the need to offer
this technique among other surgical options for all forms of pectus deformities.
877 Efficacy of thoracoscopic resection for multifocal bronchioloalveolar
carcinoma showing pure ground-glass opacities of 20 mm or less in diameter
Mingyon Mun, MD, and Tadasu Kohno, MD, Tokyo, Japan
We discuss the efficacy of video-assisted thoracic surgery for multifocal BAC. Video-assisted
thoracic surgery resection was performed in 27 patients (with 91 ground-glass opacity lesions),
and histologic diagnosis showed 62 BAC type A lesions, 28 type B lesions, and 15 type C
lesions. There were no postoperative deaths; however, new lesions have developed in 7 patients
(26%).
883 Thoracoscore predicts midterm mortality in patients undergoing thoracic
surgery
Themistocles P. Chamogeorgakis, MD, Cliff P. Connery, MD, Faiz Bhora, MD,
Andy Nabong, MA, and Ioannis K. Toumpoulis, MD, Athens, Greece, and New York, NY
We confirmed the performance of Thoracoscore in predicting in-hospital mortality in a North
American general thoracic surgery database. We also evaluated the performance of
Thoracoscore in predicting all-cause midterm mortality. Thoracoscore was a strong independent
predictor for midterm mortality and, thus, a useful clinical tool in general thoracic surgery.
Surgery for Acquired
Cardiovascular Disease
(ACD)
888 Left ventricular torsional mechanics after left ventricular reconstruction
surgery for ischemic cardiomyopathy
Randolph M. Setser, DSc, Nicholas G. Smedira, MD, Michael L. Lieber, MS, Eric D. Sabo, and
Richard D. White, MD, Cleveland, Ohio
LV systolic torsion is significantly impaired in patients with chronic ischemic cardiomyopathy,
and it is not improved by LV reconstruction surgery. However, patients with relatively worse
systolic torsion before surgery demonstrated greater improvement after surgery. Furthermore,
the rate of early diastolic untwist improved significantly after surgery.
897 Emergency repair of traumatic aortic rupture: Endovascular versus
conventional open repair
Enoch Akowuah, MD, MRCS, Andreas Baumbach, FRCP, FESC, Peter Wilde, FRCR, MRCP,
Gianni Angelini, MD, MCh, FRCS, and Alan J. Bryan, DM, FRCS (CTh), Bristol, United
Kingdom
Endovascular stenting is technically feasible and applicable to a range of patients. It takes less
time than does open repair, requires less heparin and blood products, and therefore simplifies
management of other injuries. In hemodynamically stable patients, endovascular stenting is the
treatment of choice for traumatic aortic rupture.
Table of Contents (continued)
(continued on page 14A)
12A The Journal of Thoracic and Cardiovascular Surgery ● October 2007
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
902 Analysis of 92 mitral pulmonary autograft replacement (Ross II)
operations
Sami Kabbani, MD, Hisham Jamil, MD, Fawzi Nabhani, MD, Abdo Hamoud, MD,
Karam Katan, MD, Nada Sabbagh, MD, Abir Koudsi, PhD, MD, Loay Kabbani, MD,
and Ghiath Hamed, MD, Damascus, Syria
This article presents the authors’ experience with the pulmonary autograft as a mitral valve
substitute (Ross II operation) in 90 patients with rheumatic mitral disease and in 2 patients with
congenital mitral disease, during a 7-year period ending in August 2004. Although the
operation involves significant risk, it remains an option for patients with congenital mitral
disease and young patients with rheumatic mitral disease with irreparable mitral valves when
anticoagulation is inadvisable.
909 Aortic root remodeling: Ten-year experience with 274 patients
Diana Aicher, MD, Frank Langer, MD, Henning Lausberg, MD, Benjamin Bierbach, MD, and
Hans-Joachim Scha¨fers, MD, Homburg/Saar, Germany
We have treated aortic root dilatation with preserved aortoventricular junction by remodeling.
Freedom from reoperation was 96% at 10 years. Root remodeling leads to durable restoration
of aortic valve function in both tricuspid and bicuspid valve anatomy.
916 Aortic root enlargement: What are the operative risks?
Jayesh Dhareshwar, MD, Thoralf M. Sundt III, MD, Joseph A. Dearani, MD,
Hartzell V. Schaff, MD, David J. Cook, MD, and Thomas A. Orszulak, MD, Rochester, Minn
Implantation of an aortic valve prosthesis with adequate hemodynamics in a patient with a
small aortic root can be challenging. Review of our experience with posterior aortic root
enlargement demonstrates no increased operative risk attributable to the procedure, supporting
this option as an alternative to xenograft, homograft, or autograft root replacement.
925 Response of plasma matrix metalloproteinases and tissue inhibitor of
metalloproteinases to stent-graft surgery for descending thoracic aortic
aneurysms
Mario Monaco, MD, Paolo Stassano, MD, Luigi Di Tommaso, MD, and Gabriele Iannelli, MD,
Naples, Italy
Our report investigates MMPs and their tissue endogenous inhibitor plasmatic changes in
patients who have undergone thoracic endovascular aortic repair. Preoperative levels of MMPs
in the thoracic endovascular aortic repair group were 3-fold and 2-fold higher than in the
control group. MMP values normalized after endovascular aortic repair.
932 Patterns and predictors of statin use after coronary artery bypass graft
surgery
Alexander Kulik, MD, Raisa Levin, MS, Marc Ruel, MD, MPH, Thierry G. Mesana, MD, PhD,
Daniel H. Solomon, MD, MPH, and Niteesh K. Choudhry, MD, PhD, Ottawa, Canada, and
Boston, Mass
Although the benefits of statin therapy after coronary artery bypass graft surgery are well
known, among 9284 patients, only 35.9% received statins after surgical intervention. Patients
with higher cardiovascular risk paradoxically received less statins. These results highlight the
need for initiatives to increase the rate of statin administration to this at-risk population.
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Surgery for Congenital
Heart Disease (CHD)
939 B-type natriuretic peptide levels predict outcome after neonatal cardiac
surgery
Jong-Hau Hsu, MD, Roberta L. Keller, MD, Omar Chikovani, MD, Henry Cheng, MD,
Seth A. Hollander, MD, Tom R. Karl, MD, Anthony Azakie, MD, Ian Adatia, MB, ChB,
Peter Oishi, MD, and Jeffrey R. Fineman, MD, San Francisco, Calif, and Taiwan
Perioperative BNP levels were measured in 36 neonates. A postoperative increase in BNP was
associated with low cardiac output (P  .002) and fewer ventilator-free days (P  .002), and
predicted death, an unplanned cardiac operation, or a cardiac transplant (P  .003). BNP
predicts outcome after neonatal cardiac surgery.
946 Intraoperative device closure of secundum atrial septal defect with a right
anterior minithoracotomy in 100 patients
Li Hongxin, MD, Guo Wenbin, MD, Sheng Lijun, MD, Wang Zhengjun, MD, Liang Hao, MD,
Zou Chengwei, MD, Du Liang, MD, and Yuan Guidao, MD, Jinan, China
We report our experience and current outcome in using intraoperative device closure of an
atrial septal defect through a right minithoracotomy. The possible advantages of this technique
are summarized and compared with those of surgical intervention or a transcatheter procedure.
952 Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation
in pediatric patients with refractory cardiac arrest
Bahaaldin Alsoufi, MD, Osman O. Al-Radi, MD, Rakan I. Nazer, MD,
Colleen Gruenwald, CCP, CPC, Celeste Foreman, CCP, CPC, William G. Williams, MD,
John G. Coles, MD, Christopher A. Caldarone, MD, Desmond G. Bohn, MD, and
Glen S. Van Arsdell, MD, Toronto, Ontario, Canada, and Riyadh, Saudi Arabia
ECC resuscitation with rapid deployment of ECMO provides immediate cardiovascular support
for patients with cardiac arrest unresponsive to conventional CPR measures. In our experience,
survival with intact neurologic status was achieved in 30% of patients, even after prolonged
CPR durations, thus supporting this aggressive resuscitation strategy.
960 Device closure of atrial septal defects with the Amplatzer septal occluder:
Safety and outcome in infants
Karim A. Diab, MD, Qi-Ling Cao, MD, Emile A. Bacha, MD, and Ziyad M. Hijazi, MD, MPH,
Chicago, Ill, and Boston, Mass
The efficacy and feasibility of device closure of secundum ASDs was retrospectively
investigated in small infants using the Amplatzer septal occluder. The procedure was attempted
in 15 infants (aged 0.5–11.9 months) by percutaneous or hybrid (peratrial) technique. The
success rate in the 14 infants as defined by complete closure was 86% at 24 hours and 100% at
1-year follow-up. One infant had a major complication.
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967 Determinants of repair type, reintervention, and mortality in 393 children
with double-outlet right ventricle
Timothy J. Bradley, MD, Tara Karamlou, MD, Alex Kulik, MD, Bojana Mitrovic, MD,
Trisha Vigneswaran, MD, Salima Jaffer, MD, Patrick D. Glasgow, MS,
William G. Williams, MD, Glen S. Van Arsdell, MD, and Brian W. McCrindle, MD, MPH,
Toronto, Ontario, Canada
We defined the prevalence of definitive end-states and their determinants in 393 children with
DORV. Definitive repair is currently feasible in most children with DORV. Higher early
mortality and late reintervention rates after biventricular repair must be considered in surgical
planning.
Evolving Technology
(ET)
974 Clinical application of airway bypass with paclitaxel-eluting stents: Early
results
Paulo F. G. Cardoso, MD, PhD, Gregory I. Snell, MD, MBBS, FRACP, Peter Hopkins, MD,
Gerhard W. Sybrecht, MD, Georgios Stamatis, MD, Alan W. Ng, MD, and
Philip Eng, MD, FCCP, FACP, Porto Alegre-RS, Brazil, Victoria and Brisbane, Australia,
Saarland and Essen, Germany, and Singapore
Airway bypass, a new bronchoscopic procedure for severe emphysema, was evaluated clinically
in 35 patients in a multicenter study. At 6 months, statistically significant improvements in
residual volume and dyspnea were observed. These preliminary clinical results support further
investigation of the airway bypass procedure.
982 Impact of beating heart left atrial ablation on left-sided heart mechanics
Takeyoshi Ota, MD, PhD, David Schwartzman, MD, David Francischelli, MS,
Douglas A. Hettrick, PhD, and Marco A. Zenati, MD, Pittsburgh, Pa, and Minneapolis, Minn
We examined the impact of beating heart left atrial ablation on left-sided heart mechanics using
pressure–volume and echocardiographic techniques. Radiofrequency ablation does not seem to
acutely compromise global left-sided heart mechanical function. Appendage occlusion after
ablation does not seem to compromise left-sided heart mechanical function.
989 Robot-assisted endoscopic airway reconstruction in rabbits, with the aim to
perform robot-assisted thoracoscopic bronchoplasty in human subjects
Ryuichi Waseda, MD, Norihiko Ishikawa, MD, PhD, Makoto Oda, MD, PhD,
Isao Matsumoto, MD, PhD, Yasuhiko Ohta, MD, PhD, Noriyuki Inaki, MD, PhD,
Yasumitsu Hirano, MD, PhD, and Go Watanabe, MD, PhD, Kanazawa, Japan
We examined the technical feasibility of performing safe and efficient robot-assisted hand-sewn
endoscopic airway reconstruction in a rabbit model. The technical feasibility of performing safe
and efficient robot-assisted endoscopic airway reconstruction was repeatedly demonstrated.
Robotic assistance significantly improved the time associated with and the quality of
endoscopic airway reconstruction.
Table of Contents (continued)
(continued on page 20A)
18A The Journal of Thoracic and Cardiovascular Surgery ● October 2007
ED
ITO
RIA
L
G
TS
A
CD
CH
D
ET
CSP
Cardiopulmonary
Support and Physiology
(CSP)
996 Genomic expression pathways associated with brain injury after
cardiopulmonary bypass
Basel Ramlawi, MD, Hasan Otu, PhD, James L. Rudolph, MD, Shigetoshi Mieno, MD,
Isaac S. Kohane, MD, PhD, Handan Can, PhD, Towia A. Libermann, PhD,
Edward R. Marcantonio, MD, Cesario Bianchi, MD, PhD, and Frank W. Sellke, MD,
Boston, Mass
Neurocognitive decline (NCD) after cardiac surgery is a common and widely underdiagnosed
complication caused by unclear pathophysiology. Patients with NCD had significantly different
gene-expression profiles compared with those of healthy patients. Gene expression pathways
involving inflammation, antigen presentation, and cellular adhesion might contribute to the
pathophysiology of neurologic injury after cardiopulmonary bypass.
1006 Myocardial enzyme release in totally endoscopic coronary artery bypass
grafting on the arrested heart
Thomas Schachner, MD, Nikolaos Bonaros, MD, Elisabeth Ruetzler, MD, Felix Weidinger,
Armin Oehlinger, MD, Guenther Laufer, MD, Guy Friedrich, MD, FESC, and
Johannes Bonatti, MD, FECTS, Innsbruck, Austria
Myocardial enzyme release after arrested-heart totally endoscopic coronary artery bypass
grafting is increased with longer operative times. Myocardial enzyme levels are associated with
early morbidity but do not influence mortality or myocardial pump function.
1012 Improvement of flow capacity of the left internal thoracic artery graft
assessed by using a pressure wire
Manabu Taniguchi, MD, Takashi Akasaka, MD, Yasuhiro Saito, MD, Shuichiro Kaji, MD,
Takahiro Kawamoto, MD, Renan Sukmawan, MD, Hidetoshi Yoshitani, MD, Yoji Neishi, MD,
Tohru Ohe, MD, Kazuo Tanemoto, MD, and Kiyoshi Yoshida, MD, Kurashiki and Okayama,
Japan
Eighteen patients who underwent anastomosis from the left internal thoracic artery (LITA) to
the left anterior descending coronary artery underwent coronary angiography and pressure
measurement at 1 and 6 months postoperatively. The decrease of pressure from the proximal to
the distal LITA graft became less as the LITA graft adapted itself to the myocardial circulation.
1017 Endoventricular patch plasty for dyskinetic anteroapical left ventricular
aneurysm increases systolic circumferential shortening in sheep f
Peng Zhang, MD, PhD, Julius M. Guccione, PhD, Susan I. Nicholas, MD,
Joseph C. Walker, PhD, Philip C. Crawford, CCP, Amin Shamal, MD,
Gabriel Acevedo-Bolton, PhD, Michael A. Guttman, MS, Cengizhan Ozturk, MD, PhD, and
Elliot R. McVeigh, PhD, David A. Saloner, PhD, Arthur W. Wallace, MD, PhD, and
Mark B. Ratcliffe, MD, San Francisco, Calif, and Bethesda, Md
The Dor procedure was performed on 6 sheep with anteroapical aneurysm. The Dor procedure
significantly increases systolic circumferential shortening in all noninfarcted LV regions in
sheep.
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1025 Biofilm formation on pyrolytic carbon heart valves: Influence of surface free
energy, roughness, and bacterial species
Pierre-Yves Litzler, MD, Laetitia Benard, Noe¨lle Barbier-Frebourg, MD,
Sebastien Vilain, PhD, Thierry Jouenne, PhD, Eric Beucher, Claude Bunel, PhD,
Jean-Franc¸ois Lemeland, MD, and Jean-Paul Bessou, MD, Rouen, Mont Saint Aignan,
and Louviers, France
This in vitro study analyzed the interactions of different pyrolytic carbon heart valves with
three bacterial species in biofilm formation. Biofilm formation appears dependent not only on
the bacterial species but also on physicochemical properties of pyrolytic carbon.
1033 Nitric oxide–donating aspirin (NCX 4016) inhibits neointimal thickening in
a pig model of saphenous vein–carotid artery interposition grafting: A
comparison with aspirin and morpholinosydnonimine (SIN-1)
Song Wan, FRCS, Nilima Shukla, PhD, Gianni D. Angelini, FRCS, Anthony P. C. Yim, FRCS,
Jason L. Johnson, PhD, and Jamie Y. Jeremy, PhD, Hong Kong, China, and Bristol, United
Kingdom
The oral administration of NCX 4016 elicits an inhibitory effect on neointimal thickening
in porcine vein grafts, whereas aspirin alone has little effect. NCX 4016 may be useful in
reducing the incidence of late vein graft failure in patients undergoing CABG.
Brief Communications 1040 Should large mediastinal hematomas be drained after endovascular repair of
ruptured descending thoracic aorta?
Said Yassin, MD, John Marek, MD, Jess Schwartz, MD, Jorge Wernly, MD,
Charles Dietl, MD, Stuart Pett, MD, and Mark Langsfeld, MD, Albuquerque, NM
1042 No one is dead until warm and dead
Anand Iyer, MCh, Vincent Rajkumar, Bsc, CCP, Dinesh Sadasivan, MCh, Jaye Bruce, FRACP,
and Ian Gilfillan, FRACS, Fremantle, Australia
1044 Operative strategy for open surgery after failed thoracic aortic stent grafting
Siamak Mohammadi, MD, Eric Dumont, MD, Pierre Voisine, MD, and
Franc¸ois Dagenais, MD, Quebec City, Quebec, Canada
1046 Postural change causing leg malperfusion resulting from expansion of a
patent false lumen in type B aortic dissection
Atsushi Nakahira, MD, Hitoshi Ogino, MD, Hitoshi Matsuda, MD, Kenji Minatoya, MD,
Hiroaki Sasaki, MD, Junjiro Kobayashi, MD, Toshikatsu Yagihara, MD, and
Soichiro Kitamura, MD, Osaka, Japan
1048 Successful surgical management of acute type A aortic dissection associated
with Crohn disease
John G. T. Augoustides, MD, FASE, Alberto Pochettino, MD, and Reed E. Pyeritz, MD, PhD,
Philadelphia, Pa
1049 The longest functioning heart valve prosthesis?
Stephen Westaby, MD, PhD, Lognathen Balacumaraswami, FRCSEd FRCS(CTh),
Nikant Sabharwal, MD, and Harald Becher, MD, Oxford, United Kingdom
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1051 Management of prosthetic graft infection after surgery of the thoracic aorta:
Removal of the prosthetic graft is not necessary Œ
Enoch Akowuah, MD, MRCS, Pradeep Narayan, FRCS, Gianni Angelini, MD, MCh, FRCS,
and Alan J. Bryan, DM, FRCS (C/Th), Bristol, United Kingdom
1053 Fatal thrombosis in complex cardiac surgery without deep hypothermic
circulatory arrest in the setting of standard-of-care heparinization: Status
quo and directions for further research
John G. T. Augoustides, MD, FASE, Philadelphia, Pa
1054 Late perforation of right atrium and aortic root after percutaneous closure
of patent foramen ovale
Gaetano Palma, MD, Felice Rosapepe, MD, PhD, Mariano Vicchio, MD,
Veronica Russolillo, MD, Sabato Cioffi, MD, and Carlo Vosa, MD, Naples, Italy
1055 Complicated acute type B aortic dissection with involvement of an aberrant
right subclavian artery and rupture of a thoracoabdominal aortic aneurysm,
Crawford type I: Successful emergency endovascular treatment
Victor X. Mosquera, MD, Milagros Marini, MD, PhD, Fernando Rodrı´guez, MD,
Ignacio Cao, MD, and Alberto Juffe´, MD, PhD, A Coruña, Spain
1057 Giant congenital left main coronary artery fistula to the superior vena cava
in an adult patient with coronary artery disease
Ilias A. Kouerinis, MD, PhD, Martha Deligianni, MD, Vassilios Maniatis, MD, PhD,
Ilias Elefteriadis, MD, Antonios Kourtesis, MD, and Nikolaos Michalopoulos, MD, Athens,
Greece
1059 Off-pump surgery does not reduce stroke, compared with results of on-
pump coronary artery bypass grafting: A meta-analysis of randomized
clinical trials
Hisato Takagi, MD, PhD, Toshiyuki Tanabashi, MD, Norikazu Kawai, MD, and
Takuya Umemoto, MD, PhD, Shizuoka, Japan
1061 Quadricuspid aortic valve associated with hypoplastic aortic annulus
Maria Grazia Croccia, MD, Francesca Chiaramonti, MD, Stefano Pratali, MD,
Giovanni Scioti, MD, Fabio Guarracino, MD, and Uberto Bortolotti, MD, Pisa, Italy
1062 Repair for a duplicate mitral valve with torn chordae
Kohei Ando, MD, Yukihiro Tomita, MD, Munetaka Masuda, MD, Atsuhiro Nakashima, MD,
and Ryuji Tominaga, MD, Fukuoka, Japan
1064 Arterial switch in a 1146-gram neonate with transposition of the great
arteries and an intramural coronary artery
Yukihiro Kaneko, PhD, Keiji Tsuchiya, MD, Yusuke Yamamoto, MD, Hitoshi Yoda, MD,
Wakako Yamamoto, MD, and Jotaro Kobayashi, PhD, Tokyo, Japan
1065 Norwood modification in a patient with hypoplastic left heart and a right
aortic arch
Priti M. Patel, MD, Heather L. Bartlett, MD, FACC, Thomas Scholz, MD, FACC,
Jeffrey Burzynski, MD, FACP, Douglas M. Behrendt, MD, and Harold M. Burkhart, MD, Iowa
City, Iowa
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1067 Cor triatriatum and total anomalous pulmonary venous connection to the
coronary sinus
Kazutoshi Tachibana, MD, Nobuyuki Takagi, MD, Hisayoshi Osawa, MD,
Motoki Takamuro, MD, Masato Yokozawa, MD, Hideki Tomita, MD, and Tetsuya Higami, MD,
Sapporo, Japan
1069 Fatal intraoperative thrombosis in contemporary adult thoracic aortic
surgery requiring deep hypothermic circulatory arrest: Observations from
the literature, 1993–2006
John G. T. Augoustides, MD, FASE, Philadelphia, Pa
1070 An innovative technique for the relief of right ventricular trabecular cavity
obliteration in endomyocardial fibrosis
Ana Olga Mocumbi, MD, Daniel Sidi, MD, PhD, Pascal Vouhe, MD, PhD, and
Magdi Yacoub, FRS, London, United Kingdom, Maputo, Mozambique, and Paris, France
1072 A novel technique of utilizing artificial chordae for repair of mitral valve
prolapse
Marcio Scorsin, MD, PhD, Nawwar Al-Attar, FRCS, PhD, and Arrigo Lessana, MD, Turin,
Italy, Paris, France, and St Denis, France
1073 A new surgical technique for ventricular septal rupture closure after
myocardial infarction
Luı´s Roberto Gerola, MD, PhD, Hyong C. Kim, MD, Armindo Pereira Filho, MD,
Wesley Arau´jo, MD, Paulo Ce´sar Santos, MD, and Enio Buffolo, MD, PhD, São Paulo, Brazil
1076 A case of chest wall angiosarcoma associated with breast implants
Neil D. Saunders, BS, J. Stephen Marshall, MD, and Richard C. Anderson, MD, Peoria, Ill
1078 Right lower lobectomy after right upper lobectomy for multiple metastases
in lung cancer of the right lower lobe: Benefit of middle lobe preservation
Hisashi Iwata, MD, PhD, Takuji Kiryu, MD, PhD, Koyo Shirahashi, MD,
Shinsuke Matsumoto, MD, Masafumi Matsui, MD, and Hirofumi Takemura, MD, PhD, Gifu,
Japan
1080 Fibroepithelial polyps: Preoperative diagnosis may avoid thoracotomy
Christopher T. Wartmann, MD, Denise Fernandez, BA, and Raja M. Flores, MD, Chicago, Ill,
and New York, NY
1082 A giant thoracic duct cyst: An unusual cause of dysphagia
Atila Turkyilmaz, MD, and Atilla Eroglu, MD, Erzurum, Turkey
1084 Esophageal stent migration into the trachea
Massimo Conti, MD, Pasquale Ferraro, MD, Jocelyne Martin, MD, and
Andre´ Duranceau, MD, Montre´al, Quebec, Canada
1086 Successful management of recurrent Actinomyces esophagobronchial fistula
with self-expanding covered esophageal stent
Hyde M. Russell, MD, Alberto L. de Hoyos, MD, and Matthew G. Blum, MD, Chicago, Ill
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1088 Video-assisted thoracoscopic extrapleural pneumonectomy for malignant
pleural mesothelioma
Takashi Suda, MD, Yuka Kitamura, MD, Sachiko Hasegawa, MD, Koji Negi, MD, and
Yoshinobu Hattori, MD, Aichi, Japan
1090 Middle lobe torsion after right upper lobectomy: A report of video-assisted
thoracoscopic management
Charles C. Sticco, DO, Shahriyour Andaz, MD, FACS, and Stewart Fox, MD, FACS,
Oceanside, NY
1092 Living-donor single-lobe lung transplantation for bronchiolitis obliterans in a
4-year-old boy
Takeshi Shiraishi, MD, Masafumi Hiratsuka, MD, Mitsuteru Munakata, MD,
Takao Higuchi, MD, Satoshi Makihata, MD, Yasuteru Yoshinaga, MD, Satoshi Yamamoto, MD,
Akinori Iwasaki, MD, Masanobu Yasumoto, MD, Takamitsu Hamada, MD, Kazuo Higa, MD,
Takashige Kuraki, MD, Kentaro Watanabe, MD, Noritsugu Morishige, MD,
Tadashi Tashiro, MD, Kazuki Nabeshima, MD, Katsunobu Kawahara, MD,
Kan Okabayashi, MD, Hiroshi Yasunaga, MD, and Takayuki Shirakusa, MD, Fukuoka City,
Oita, Koga City, and Kurume City, Japan
Letters to the Editor 1094 Selective replacement of the noncoronary sinus of Valsalva: Preserving the
sinus geometry to spare the bicuspid aortic valve
Alfredo Giuseppe Cerillo, MD, Pier Andrea Farneti, MD, and Mattia Glauber, MD, Massa,
Italy
1095 Reply
Francesca di Marco, MD, PhD, Sara Pontarollo, MD, Sabino Illiceto, MD, and
Gino Gerosa, MD, Padua, Italy
1095 Rescue versus regeneration
Christof Stamm, MD, Boris Nasseri, MD, and Roland Hetzer, MD, Berlin, Germany
1096 Reply
Tao-Sheng Li, MD, Ryo Suzuki, MD, and Kimikazu Hamano, MD, Ube, Yamaguchi, Japan
1097 Pulmonary metastatic melanoma
Mohamed Fouad Ismail, MD, Mansoura, Egypt
1097 Superior vena cava resection without blood flow interruption
Claudio Rossella, MD, and Stefano Nazari, MD, Cotignola, RA and Pavia, Italy
1098 Reply
Francesco Leo, MD, PhD, and Lorenzo Spaggiari, MD, PhD, Milan, Italy
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1101 Announcement of 2008 Annual Meeting
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